CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 100 shares, a decrease of 98.0% from the November 15th total of 4,900 shares. Based on an average daily volume of 34,700 shares, the days-to-cover ratio is currently 0.0 days.
CSPC Pharmaceutical Group Stock Performance
CSPC Pharmaceutical Group stock traded down C$0.11 during midday trading on Wednesday, reaching C$2.57. The stock had a trading volume of 13,288 shares, compared to its average volume of 40,351. CSPC Pharmaceutical Group has a 52-week low of C$2.25 and a 52-week high of C$3.82. The company has a fifty day moving average of C$2.90 and a 200 day moving average of C$2.92.
CSPC Pharmaceutical Group Increases Dividend
The company also recently disclosed a dividend, which was paid on Thursday, December 5th. Shareholders of record on Friday, November 1st were issued a $0.0575 dividend. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date of this dividend was Friday, November 1st.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
Featured Articles
- Five stocks we like better than CSPC Pharmaceutical Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- The Great CPU Race: AMD and Intel Battle for Dominance
- Dividend Capture Strategy: What You Need to Know
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- How to Use High Beta Stocks to Maximize Your Investing Profits
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.